Ruben Gennero Riganti currently serves as the Director Médico at Clínica Dávila Vespucio since August 2024. Previously, this professional held several leadership positions, including Gerente General at Hospital Clínico Dra. Eloísa Díaz I. La Florida from July 2020 to August 2024 and Jefe División Gestion de Redes Asistenciales at Ministerio de Salud de Chile from July 2019 to March 2020. Additional experience includes roles such as Director at Hospital La Florida and Jefe Departamento Gestión de Información e Innovación at Hospital Santiago Oriente. Ruben's background also encompasses significant positions in the pharmaceutical sector, including Head of Market Access & Commercial at Novartis Oncology and Associate Director for Global Health Economics & Outcome Research at Teva Pharmaceuticals. Ruben holds an MBA from Pontificia Universidad Católica de Chile, a Master of Public Health from Imperial College London, and a medical degree from Pontificia Universidad Católica de Chile.